Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | ACACB | O00763 | 4/20 | 0.52 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | TPH1 | P17752 | 1/20 | 0.39 |
| ▸ | GRB2 | P62993 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4946470 | 1.00 | PTPN1 (0.52) | PTPN1ACACBSCN10AEPHX1PPARA | |
| SCHEMBL17658724 | 0.89 | PTPN1 (0.54) | PTPN1ACACBPPARAPPARGITGB3 | |
| SCHEMBL2867832 | 0.87 | PTPN1 (0.68) | PTPN1ACACBPPARGITGB3ITGA2B | |
| SCHEMBL2118353 | 0.87 | PTPN1 (0.68) | PTPN1ACACBPPARGITGB3ITGA2B | |
| SCHEMBL1258519 | 0.87 | PTPN1 (0.68) | PTPN1ACACBPPARGITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL2309162 | 0.86 | PTPN1 (0.67) | PTPN1ACACBITGB3ITGA2BSLC7A5 | |
| SCHEMBL3729750 | 0.84 | ACACB (0.50) | PTPN1ACACBPPARAPPARGITGB3 | |
| SCHEMBL4472407 | 0.84 | ACACB (0.53) | PTPN1ACACBPPARAPPARGITGB3 | |
| SCHEMBL2058886 | 0.84 | ACACB (0.53) | PTPN1ACACBPPARAPPARGITGB3 | |
| SCHEMBL2311151 | 0.84 | ACACB (0.50) | PTPN1ACACBPPARAPPARGITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
| US-7456201-B2 | Pharmaceutically active compounds and methods of use | LABORATOIRES SERONO SA (CH) | 2008-11-25 | — | — | US | disclosed |
| EP-1441724-B8 | METHODS OF INCREASING ENDOGENOUS TESTOSTERONE LEVELS | SERONO LAB (CH) | 2007-10-17 | — | — | EP | disclosed |
| EP-1441724-B1 | METHODS OF INCREASING ENDOGENOUS TESTOSTERONE LEVELS | APPLIED RESEARCH SYSTEMS (AN) | 2007-09-05 | — | — | EP | disclosed |
| EP-1282418-B1 | USE OF PYRAZOLE DERIVATIVES FOR TREATING INFERTILITY | APPLIED RESEARCH SYSTEMS (AN) | 2005-08-17 | — | — | EP | disclosed |
| US-6914069-B2 | Pharmaceutically active compounds and methods of use | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2005-07-05 | — | — | US | disclosed |
| US-20050026985-A1 | Pharmaceutically active compounds and methods of use | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. | 2005-02-03 | — | — | US | disclosed |
| US-20040198799-A1 | Methods of increasing endogenous testosterone levels | LABORATOIRES SERONO SA (CH) | 2004-10-07 | — | — | US | disclosed |
| EP-1441724-A1 | METHODS OF INCREASING ENDOGENOUS TESTOSTERONE LEVELS | Applied Research Systems ARS Holding S.A. (AN) | 2004-08-04 | — | — | EP | disclosed |
| WO-2003026649-A1 | METHODS OF INCREASING ENDOGENOUS TESTOSTERONE LEVELS | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2003-04-03 | — | — | WO | disclosed |
| EP-1282418-A2 | USE OF PYRAZOLE DERIVATIVES FOR TREATING INFERTILITY | Serono Reproductive Biology Institute, Inc. (US) | 2003-02-12 | — | — | EP | disclosed |
| US-20020132844-A1 | Pharmaceutically active compounds and methods of use | MERCK SERONO SA (CH) | 2002-09-19 | — | — | US | disclosed |
| WO-2001087287-A2 | USE OF PYRAZOLE DERIVATIVES FOR TREATING INFERTILITY | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2001-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198799-A1 | Methods of increasing endogenous testosterone levels | SHBG, CYP17A1, NR5A1 | PTPN1 4222/4885ACACB 1054/4885SCN10A 3779/4885 |
| US-20020132844-A1 | Pharmaceutically active compounds and methods of use | CATSPER1, NASP, ACR | PTPN1 3403/4885ACACB 1296/4885SCN10A 3547/4885 |
| US-20050026985-A1 | Pharmaceutically active compounds and methods of use | CATSPER1, NASP, ACR | PTPN1 3403/4885ACACB 1296/4885SCN10A 3547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.